ICPT Intercept Pharmaceuticals, Inc. Company Research Saturday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
ICPT Intercept Pharmaceuticals, Inc. $ICPT Company Overview 

Stock Message Board http://investorshangout.com/search?q=ICPT&...mp;yt1=Go!

Last Updated: Saturday, January 11, 2014 10:16:16 PM

Intercept Pharmaceuticals, Inc. ICPT Current Price and Quotes
Last Price 445.83
Previous Close 275.87 Open 373.00
Daily Range 497.00 - 373.00 52wk Range 305.00 - 30.38
Volume 5,982,532 Dividend N/A
Average Vol (3m) 393,994 Yield N/A
Intercept Pharmaceuticals, Inc. ICPT
Company Information



Intercept Pharmaceuticals, Inc. ICPT
Intercept Pharmaceuticals, Inc. ICPT
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Latest Report Sep 30, 2013 10-Q
Fiscal Year End Not Available
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In:
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Intercept Pharmaceuticals, Inc. ICPT
ICPT Security Details

Share Structure

Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value  Not Available
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest  (%)
Significant Failures to Deliver  No
Transfer Agent(s)



Intercept Pharmaceuticals, Inc. ICPT Financials
Period Ending Dec 31, 2012
Total Revenue 2,446
Cost of Revenue -
Gross Profit 2,446
Operating Expenses

Research and Development 16,183
Sales, General and Admin. 5,177
Non-Recurring Items -
Other -
Operating Income (18,914)
Income From Continuing Operations

Add'l Income/Expense Items (24,729)
Earnings Before Interest and Tax (43,643)
Interest Expense -
Earnings Before Tax (43,643)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (43,643)
Non Recurring Events

Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (43,643)
Preferred Stock and Other Adjustments (2,630)
Net Income Applicable to Common Shareholders (46,274)

Intercept Pharmaceuticals, Inc. ICPT Recent News

Jan 10, 2014 Intercept to Present at the J.P. Morgan Healthcare Conference
Jan 10, 2014 Drug trial vaults value of small bio-tech firm to $5.3 billion
Jan 9, 2014 Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones
Jan 9, 2014 Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology
Jan 2, 2014 Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9
Dec 18, 2013 Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept
Dec 9, 2013 INTERCEPT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Intercept Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty
Nov 20, 2013 Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
Nov 14, 2013 Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
Oct 23, 2013 Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva


ICPT Intercept Pharmaceuticals, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ICPT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ICPT/quote
Stock Chart http://www.otcmarkets.com/stock/ICPT/chart
Company Info http://www.otcmarkets.com/stock/ICPT/company-info
Recent News http://www.otcmarkets.com/stock/ICPT/news
Financials http://www.otcmarkets.com/stock/ICPT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ICPT/filings
Short Sales http://www.otcmarkets.com/stock/ICPT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ICPT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ICPT/research
Summary http://finance.yahoo.com/q?s=ICPT
Historical Prices http://finance.yahoo.com/q/hp?s=ICPT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ICPT
Basic Chart http://finance.yahoo.com/q/bc?s=ICPT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ICPT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ICPT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ICPT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ICPT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ICPT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ICPT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ICPT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ICPT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ICPT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ICPT
Balance Sheet http://finance.yahoo.com/q/bs?s=ICPT
Cash Flow http://finance.yahoo.com/q/cf?s=ICPT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ICPT
Market Watch http://www.marketwatch.com/investing/stock/ICPT
Bloomberg http://www.bloomberg.com/quote/ICPT:US
Morningstar http://quotes.morningstar.com/stock/s?t=ICPT
Bussinessweek http://investing.businessweek.com/research/st...icker=ICPT
Barchart http://www.barchart.com/quotes/stocks/ICPT
OTC Short Report http://otcshortreport.com/index.php?index=ICPT
Investopedia http://www.investopedia.com/markets/stocks/ICPT/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 35

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 19

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 47

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 31

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

ConocoPhillips Prepares for Third Quarter Earnings Report

Updated Category News Views 132

ConocoPhillips Earnings Preview ConocoPhillips (NYSE: COP) is set to unveil its earnings results for the third quarter, drawing significant attention from investors and analysts alike. This report is expected to be released before the opening bell on the designated Thursday. Analysts project that ConocoPhillips will report earnings of $1.41 per share, a decrease from...

Continue Reading
Tesla's FSD Ambitions Shine Amid Market Uncertainty

Updated Category News Views 138

Tesla's Ambitious Goals for Full Self-Driving Technology Tesla, Inc. TSLA is pursuing an ambitious plan to introduce its groundbreaking full self-driving (FSD) technology to markets around the world, with a particular focus on regions in Asia and Europe. What to Anticipate from Tesla's FSD Launch Industry expert Greg Migliore, editor-in-chief of Real Auto Blog, bel

Continue Reading
Centners Pursue $885M Defamation Case Against Local Newspaper

Updated Category News Views 230

Centners File Major Defamation Lawsuit Against a Newspaper Philanthropists and entrepreneurs David and Leila Centner have taken a significant step by initiating a defamation lawsuit against a prominent newspaper and several journalists. They are asserting that the newspaper has intentionally misrepresented public records regarding their generous donation intentions aimed...

Continue Reading
NACCO Industries Reports Solid Performance Amid Challenges

Updated Category News Views 140

NACCO Industries Announces Second Quarter Results NACCO Industries, Inc. (NYSE: NC) has revealed its consolidated results for the three and six months ending in June 2025. The company faced some short-term operational challenges, impacting their ability to meet expected growth targets. Despite this setback, NACCO's versatile sectors remain primed for recovery and...

Continue Reading
Unlocking Income: Earning $500 Monthly from Jefferies Stock

Updated Category News Views 100

Understanding Jefferies Financial Group Inc. Jefferies Financial Group Inc. (NYSE: JEF) is a key player in the financial services sector, known for its robust investment banking operations and diverse financial solutions. With the company's upcoming earnings report for the fourth quarter, there’s excitement surrounding its performance and future potential. Although the...

Continue Reading